United Laboratories International Holdings akcijos akcijų analizė | Akcijų kaina | Naujienos | 3933.HK | KYG8813K1085 | A0MUFS

Data	United Laboratories International Holdings Pajamos	United Laboratories International Holdings EBIT	United Laboratories International Holdings Pelnas
2026e	16,37 mlrd. CNY	3,32 mlrd. CNY	2,82 mlrd. CNY
2025e	15,76 mlrd. CNY	3,23 mlrd. CNY	2,73 mlrd. CNY
2024e	15,09 mlrd. CNY	3,32 mlrd. CNY	2,80 mlrd. CNY
2023	13,74 mlrd. CNY	3,28 mlrd. CNY	2,70 mlrd. CNY
2022	11,33 mlrd. CNY	2,11 mlrd. CNY	1,58 mlrd. CNY
2021	9,70 mlrd. CNY	1,16 mlrd. CNY	988,10 mln. CNY
2020	8,77 mlrd. CNY	1,25 mlrd. CNY	702,99 mln. CNY
2019	8,39 mlrd. CNY	1,08 mlrd. CNY	641,76 mln. CNY
2018	7,51 mlrd. CNY	1,01 mlrd. CNY	682,93 mln. CNY
2017	6,83 mlrd. CNY	689,11 mln. CNY	81,76 mln. CNY
2016	6,08 mlrd. CNY	408,18 mln. CNY	−272,36 mln. CNY
2015	6,74 mlrd. CNY	741,62 mln. CNY	96,69 mln. CNY
2014	7,19 mlrd. CNY	1,29 mlrd. CNY	609,78 mln. CNY
2013	6,06 mlrd. CNY	409,20 mln. CNY	38,10 mln. CNY
2012	5,71 mlrd. CNY	315,80 mln. CNY	131,70 mln. CNY
2011	5,32 mlrd. CNY	276,10 mln. CNY	86,60 mln. CNY
2010	5,67 mlrd. CNY	1,08 mlrd. CNY	848,80 mln. CNY
2009	4,09 mlrd. CNY	706,40 mln. CNY	477,10 mln. CNY
2008	3,35 mlrd. CNY	559,00 mln. CNY	383,90 mln. CNY
2007	2,53 mlrd. CNY	613,60 mln. CNY	497,60 mln. CNY
2006	2,13 mlrd. CNY	305,00 mln. CNY	178,40 mln. CNY
2005	1,81 mlrd. CNY	243,40 mln. CNY	122,70 mln. CNY
2004	1,28 mlrd. CNY	212,60 mln. CNY	140,40 mln. CNY

	Pajamos	EBIT	Pelnas
2004	1,28 mlrd. CNY	212,60 mln. CNY	140,40 mln. CNY
2005	1,81 mlrd. CNY	243,40 mln. CNY	122,70 mln. CNY
2006	2,13 mlrd. CNY	305,00 mln. CNY	178,40 mln. CNY
2007	2,53 mlrd. CNY	613,60 mln. CNY	497,60 mln. CNY
2008	3,35 mlrd. CNY	559,00 mln. CNY	383,90 mln. CNY
2009	4,09 mlrd. CNY	706,40 mln. CNY	477,10 mln. CNY
2010	5,67 mlrd. CNY	1,08 mlrd. CNY	848,80 mln. CNY
2011	5,32 mlrd. CNY	276,10 mln. CNY	86,60 mln. CNY
2012	5,71 mlrd. CNY	315,80 mln. CNY	131,70 mln. CNY
2013	6,06 mlrd. CNY	409,20 mln. CNY	38,10 mln. CNY
2014	7,19 mlrd. CNY	1,29 mlrd. CNY	609,78 mln. CNY
2015	6,74 mlrd. CNY	741,62 mln. CNY	96,69 mln. CNY
2016	6,08 mlrd. CNY	408,18 mln. CNY	−272,36 mln. CNY
2017	6,83 mlrd. CNY	689,11 mln. CNY	81,76 mln. CNY
2018	7,51 mlrd. CNY	1,01 mlrd. CNY	682,93 mln. CNY
2019	8,39 mlrd. CNY	1,08 mlrd. CNY	641,76 mln. CNY
2020	8,77 mlrd. CNY	1,25 mlrd. CNY	702,99 mln. CNY
2021	9,70 mlrd. CNY	1,16 mlrd. CNY	988,10 mln. CNY
2022	11,33 mlrd. CNY	2,11 mlrd. CNY	1,58 mlrd. CNY
2023	13,74 mlrd. CNY	3,28 mlrd. CNY	2,70 mlrd. CNY
2024e	15,09 mlrd. CNY	3,32 mlrd. CNY	2,80 mlrd. CNY
2025e	15,76 mlrd. CNY	3,23 mlrd. CNY	2,73 mlrd. CNY
2026e	16,37 mlrd. CNY	3,32 mlrd. CNY	2,82 mlrd. CNY

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0,19	0,18	0,23	0,54	0,48	0,61	1,01	0,15	0,20	0,71	0,61	0,20	−0,14	0,07	0,79	0,84	0,88	1,20	2,01
90,00	119,00	196,00	179,00	223,00	295,00	362,00	377,00	436,00	451,00	647,00	687,00	710,00	784,00	741,00	675,00	614,00	620,00	552,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
−80,00	−161,00	−215,00	−458,00	−161,00	−336,00	−870,00	−276,00	−271,00	260,00	−2,00	187,00	71,00	−554,00	−551,00	9,00	−226,00	−495,00	−587,00
34,00	70,00	84,00	85,00	81,00	83,00	76,00	168,00	113,00	−254,00	425,00	455,00	429,00	471,00	230,00	274,00	297,00	214,00	58,00
30,00	66,00	75,00	73,00	104,00	93,00	100,00	145,00	253,00	348,00	432,00	308,00	281,00	223,00	203,00	215,00	124,00	50,00	75,00
39,00	48,00	55,00	70,00	51,00	83,00	144,00	115,00	86,00	92,00	155,00	139,00	137,00	192,00	190,00	158,00	154,00	236,00	299,00
0,23	0,21	0,29	0,35	0,62	0,65	0,58	0,42	0,48	1,17	1,68	1,53	1,07	0,77	1,21	1,80	1,57	1,54	2,03
−546,00	−417,00	−150,00	−803,00	−1 004,00	−755,00	−948,00	−1 031,00	−2 320,00	−1 622,00	−640,00	−652,00	−403,00	−458,00	−477,00	−384,00	−530,00	−482,00	−818,00
−708,00	−466,00	−449,00	−845,00	−931,00	−751,00	−1 006,00	−1 172,00	−2 839,00	−1 251,00	−1 053,00	−317,00	−527,00	87,00	−555,00	−433,00	166,00	−587,00	−594,00
−162,00	−48,00	−299,00	−42,00	73,00	4,00	−58,00	−141,00	−518,00	370,00	−413,00	335,00	−124,00	545,00	−77,00	−49,00	697,00	−105,00	223,00
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0,34	0,29	0,10	0,00	0,28	0,37	0,06	1,55	1,80	0,84	−0,18	−0,72	0,54	−0,87	−0,53	0,63	−1,66	−0,32	0,32
0	0	0	0,80	0	0	1,05	0	0,58	0	0	0	0	0	0	0	0	−0,04	−0,04
0,34	0,29	0,10	0,77	0,10	0,12	0,66	1,14	2,11	0,41	−0,68	−1,08	0,29	−1,04	−0,77	0,32	−1,91	−0,62	−0,02
-	-	-	−43,00	-	−93,00	−115,00	−178,00	−268,00	−428,00	−501,00	−360,00	−252,00	−171,00	−151,00	−215,00	−122,00	−41,00	−33,00
0	0	0	0	−182,00	−158,00	−337,00	−226,00	0	0	0	0	0	0	−84,00	−98,00	−128,00	−220,00	−272,00
−0,14	0,04	−0,06	0,30	−0,21	0,03	0,24	0,40	−0,25	0,34	−0,07	0,09	0,85	−0,19	−0,11	1,68	−0,17	0,33	1,41
−314,40	−205,50	142,10	−452,00	−385,80	−101,60	−365,90	−608,90	−1 840,30	−449,40	1 036,74	876,78	670,77	311,83	735,67	1 417,15	1 037,07	1 060,38	1 212,08
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

United Laboratories International Holdings Bruto marža	United Laboratories International Holdings Pelnas-martža	United Laboratories International Holdings EBIT marža	United Laboratories International Holdings Pelnas-martža
2026e	46,11 %	20,28 %	17,20 %
2025e	46,11 %	20,50 %	17,34 %
2024e	46,11 %	21,98 %	18,53 %
2023	46,11 %	23,89 %	19,66 %
2022	43,84 %	18,58 %	13,95 %
2021	43,40 %	11,95 %	10,18 %
2020	43,39 %	14,26 %	8,01 %
2019	43,15 %	12,87 %	7,65 %
2018	40,64 %	13,39 %	9,09 %
2017	36,60 %	10,09 %	1,20 %
2016	35,58 %	6,72 %	−4,48 %
2015	38,48 %	11,00 %	1,43 %
2014	40,20 %	17,97 %	8,48 %
2013	34,49 %	6,75 %	0,63 %
2012	30,15 %	5,53 %	2,31 %
2011	28,55 %	5,19 %	1,63 %
2010	39,49 %	18,98 %	14,98 %
2009	39,07 %	17,26 %	11,66 %
2008	38,06 %	16,68 %	11,45 %
2007	46,47 %	24,26 %	19,67 %
2006	35,39 %	14,29 %	8,36 %
2005	34,86 %	13,43 %	6,77 %
2004	33,21 %	16,67 %	11,01 %

	Bruto marža	EBIT marža	Pelnas-martža
2004	33,21 %	16,67 %	11,01 %
2005	34,86 %	13,43 %	6,77 %
2006	35,39 %	14,29 %	8,36 %
2007	46,47 %	24,26 %	19,67 %
2008	38,06 %	16,68 %	11,45 %
2009	39,07 %	17,26 %	11,66 %
2010	39,49 %	18,98 %	14,98 %
2011	28,55 %	5,19 %	1,63 %
2012	30,15 %	5,53 %	2,31 %
2013	34,49 %	6,75 %	0,63 %
2014	40,20 %	17,97 %	8,48 %
2015	38,48 %	11,00 %	1,43 %
2016	35,58 %	6,72 %	−4,48 %
2017	36,60 %	10,09 %	1,20 %
2018	40,64 %	13,39 %	9,09 %
2019	43,15 %	12,87 %	7,65 %
2020	43,39 %	14,26 %	8,01 %
2021	43,40 %	11,95 %	10,18 %
2022	43,84 %	18,58 %	13,95 %
2023	46,11 %	23,89 %	19,66 %
2024e	46,11 %	21,98 %	18,53 %
2025e	46,11 %	20,50 %	17,34 %
2026e	46,11 %	20,28 %	17,20 %

Data	United Laboratories International Holdings Pardavimai vienai akcijai	United Laboratories International Holdings EBIT vienai akcijai	United Laboratories International Holdings Pelnas vienai akcijai
2026e	9,01 CNY	0 CNY	1,55 CNY
2025e	8,67 CNY	0 CNY	1,50 CNY
2024e	8,30 CNY	0 CNY	1,54 CNY
2023	7,56 CNY	1,81 CNY	1,49 CNY
2022	6,23 CNY	1,16 CNY	0,87 CNY
2021	5,27 CNY	0,63 CNY	0,54 CNY
2020	4,97 CNY	0,71 CNY	0,40 CNY
2019	5,12 CNY	0,66 CNY	0,39 CNY
2018	4,09 CNY	0,55 CNY	0,37 CNY
2017	4,20 CNY	0,42 CNY	0,05 CNY
2016	3,74 CNY	0,25 CNY	−0,17 CNY
2015	4,14 CNY	0,46 CNY	0,06 CNY
2014	4,42 CNY	0,79 CNY	0,37 CNY
2013	3,73 CNY	0,25 CNY	0,02 CNY
2012	3,77 CNY	0,21 CNY	0,09 CNY
2011	3,70 CNY	0,19 CNY	0,06 CNY
2010	4,17 CNY	0,79 CNY	0,63 CNY
2009	3,13 CNY	0,54 CNY	0,36 CNY
2008	2,56 CNY	0,43 CNY	0,29 CNY
2007	2,18 CNY	0,53 CNY	0,43 CNY
2006	2,18 CNY	0,31 CNY	0,18 CNY
2005	1,85 CNY	0,25 CNY	0,13 CNY
2004	1,30 CNY	0,22 CNY	0,14 CNY

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2004	1,30 CNY	0,22 CNY	0,14 CNY
2005	1,85 CNY	0,25 CNY	0,13 CNY
2006	2,18 CNY	0,31 CNY	0,18 CNY
2007	2,18 CNY	0,53 CNY	0,43 CNY
2008	2,56 CNY	0,43 CNY	0,29 CNY
2009	3,13 CNY	0,54 CNY	0,36 CNY
2010	4,17 CNY	0,79 CNY	0,63 CNY
2011	3,70 CNY	0,19 CNY	0,06 CNY
2012	3,77 CNY	0,21 CNY	0,09 CNY
2013	3,73 CNY	0,25 CNY	0,02 CNY
2014	4,42 CNY	0,79 CNY	0,37 CNY
2015	4,14 CNY	0,46 CNY	0,06 CNY
2016	3,74 CNY	0,25 CNY	−0,17 CNY
2017	4,20 CNY	0,42 CNY	0,05 CNY
2018	4,09 CNY	0,55 CNY	0,37 CNY
2019	5,12 CNY	0,66 CNY	0,39 CNY
2020	4,97 CNY	0,71 CNY	0,40 CNY
2021	5,27 CNY	0,63 CNY	0,54 CNY
2022	6,23 CNY	1,16 CNY	0,87 CNY
2023	7,56 CNY	1,81 CNY	1,49 CNY
2024e	8,30 CNY	0 CNY	1,54 CNY
2025e	8,67 CNY	0 CNY	1,50 CNY
2026e	9,01 CNY	0 CNY	1,55 CNY

	Akcijų skaičius
2004	980,50 mln. Aktien
2005	980,50 mln. Aktien
2006	980,50 mln. Aktien
2007	1,16 mlrd. Aktien
2008	1,31 mlrd. Aktien
2009	1,31 mlrd. Aktien
2010	1,36 mlrd. Aktien
2011	1,44 mlrd. Aktien
2012	1,51 mlrd. Aktien
2013	1,63 mlrd. Aktien
2014	1,63 mlrd. Aktien
2015	1,63 mlrd. Aktien
2016	1,63 mlrd. Aktien
2017	1,63 mlrd. Aktien
2018	1,83 mlrd. Aktien
2019	1,64 mlrd. Aktien
2020	1,77 mlrd. Aktien
2021	1,84 mlrd. Aktien
2022	1,82 mlrd. Aktien
2023	1,82 mlrd. Aktien
2024e	1,82 mlrd. Aktien
2025e	1,82 mlrd. Aktien
2026e	1,82 mlrd. Aktien

Data	United Laboratories International Holdings Dividendas
2026e	0,22 CNY
2025e	0,22 CNY
2024e	0,22 CNY
2023	0,20 CNY
2022	0,08 CNY
2021	0,14 CNY
2020	0,08 CNY
2019	0,07 CNY
2018	0,06 CNY
2011	0,19 CNY
2010	0,28 CNY
2009	0,14 CNY
2008	0,16 CNY

	Dividendas	Dividenda (įvertinimas)
2004	0 CNY	0 CNY
2005	0 CNY	0 CNY
2006	0 CNY	0 CNY
2007	0 CNY	0 CNY
2008	0,16 CNY	0 CNY
2009	0,14 CNY	0 CNY
2010	0,28 CNY	0 CNY
2011	0,19 CNY	0 CNY
2012	0 CNY	0 CNY
2013	0 CNY	0 CNY
2014	0 CNY	0 CNY
2015	0 CNY	0 CNY
2016	0 CNY	0 CNY
2017	0 CNY	0 CNY
2018	0,06 CNY	0 CNY
2019	0,07 CNY	0 CNY
2020	0,08 CNY	0 CNY
2021	0,14 CNY	0 CNY
2022	0,08 CNY	0 CNY
2023	0,20 CNY	0 CNY
2024e	0 CNY	0,22 CNY
2025e	0 CNY	0,22 CNY
2026e	0 CNY	0,22 CNY

Data	United Laboratories International Holdings Išmokėjimo santykis
2026e	17,34 %
2025e	15,31 %
2024e	18,23 %
2023	18,49 %
2022	9,22 %
2021	26,98 %
2020	19,25 %
2019	17,44 %
2018	16,57 %
2017	18,49 %
2016	18,49 %
2015	18,49 %
2014	18,49 %
2013	18,49 %
2012	18,49 %
2011	321,25 %
2010	45,16 %
2009	38,24 %
2008	53,81 %
2007	18,49 %
2006	18,49 %
2005	18,49 %
2004	18,49 %

	Išmokėjimo santykis
2004	18,49 %
2005	18,49 %
2006	18,49 %
2007	18,49 %
2008	53,81 %
2009	38,24 %
2010	45,16 %
2011	321,25 %
2012	18,49 %
2013	18,49 %
2014	18,49 %
2015	18,49 %
2016	18,49 %
2017	18,49 %
2018	16,57 %
2019	17,44 %
2020	19,25 %
2021	26,98 %
2022	9,22 %
2023	18,49 %
2024e	18,23 %
2025e	15,31 %
2026e	17,34 %

Data	EPS-prognozė	EPS-Faktinis	Pranešimo ketvirtis
2023-12-31	0,74 CNY	0,78 CNY (4,75 %)	2023 Q4
2023-06-30	0,36 CNY	0,71 CNY (98,04 %)	2023 Q2
2022-12-31	0,29 CNY	0,52 CNY (83,12 %)	2022 Q4
2022-06-30	0,29 CNY	0,35 CNY (21,15 %)	2022 Q2
2021-12-31	0,31 CNY	0,20 CNY (−35,29 %)	2021 Q4
2021-06-30	0,27 CNY	0,34 CNY (27,83 %)	2021 Q2
2020-12-31	0,31 CNY	0,28 CNY (−9,15 %)	2020 Q4
2020-06-30	0,24 CNY	0,12 CNY (−50,98 %)	2020 Q2
2019-12-31	0,17 CNY	0,19 CNY (11,30 %)	2019 Q4
2018-12-31	0,13 CNY	0,08 CNY (−39,94 %)	2018 Q4
2018-06-30	0,16 CNY	0,26 CNY (68,27 %)	2018 Q2
2017-12-31	0,11 CNY	0,20 CNY (83,52 %)	2017 Q4
2017-06-30	0,08 CNY	0,09 CNY (4,07 %)	2017 Q2
2016-06-30	0,10 CNY	−0,01 CNY (−107,65 %)	2016 Q2
2015-12-31	0,13 CNY	−0,14 CNY (−207,26 %)	2015 Q4
2015-06-30	0,15 CNY	0,22 CNY (44,65 %)	2015 Q2
2014-12-31	0,13 CNY	−0,01 CNY (−110,07 %)	2014 Q4
2013-06-30	0,03 CNY	0,02 CNY (−35,79 %)	2013 Q2
2012-12-31	0,07 CNY	−0,00 CNY (−104,96 %)	2012 Q4
2012-06-30	0,04 CNY	0,06 CNY (36,39 %)	2012 Q2
2011-12-31	0,15 CNY	−0,11 CNY (−173,78 %)	2011 Q4
2011-06-30	0,36 CNY	0,18 CNY (−48,87 %)	2011 Q2
2010-12-31	0,29 CNY	0,30 CNY (4,85 %)	2010 Q4
2010-06-30	0,16 CNY	0,32 CNY (96,36 %)	2010 Q2

%	Pavadinimas	Akcijos	Pokytis	Data
45,91 %	Heren Far East Ltd.	834 250 000	−64 000 000	2023-09-21
1,63 %	Dimensional Fund Advisors, L.P.	29 609 500	−78 000	2024-03-31
1,52 %	The Vanguard Group, Inc.	27 631 235	150 000	2024-03-31
0,90 %	Tsoi (Hoi Shan)	16 306 875	0	2023-11-30
0,88 %	Bosera Asset Management Co., Ltd.	16 028 000	3 912 000	2023-12-31
0,81 %	Victory Capital Management Inc.	14 682 000	2 866 000	2023-12-31
0,72 %	GF Fund Management Co., Ltd.	13 092 000	7 764 000	2023-12-31
0,71 %	Goldman Sachs Asset Management, L.P.	12 842 000	0	2024-02-29
0,69 %	Avantis Investors	12 574 000	114 000	2024-03-31
0,65 %	Allianz Global Investors GmbH	11 735 937	−246 000	2024-02-29
0,63 %	Norges Bank Investment Management (NBIM)	11 369 539	−591 319	2023-12-31
0,59 %	BlackRock Institutional Trust Company, N.A.	10 792 000	−128 000	2024-03-31
0,45 %	China Universal Asset Management Co., Ltd.	8 164 000	−2 930 000	2023-12-31
0,40 %	Baillie Gifford & Co.	7 274 000	436 000	2024-01-31
0,34 %	Nordea Investment Management AB (Denmark)	6 186 000	−28 000	2024-02-29
0,31 %	Florida State Board of Administration	5 674 306	−879 793	2022-09-30
0,25 %	China Asset Management Co., Ltd.	4 540 000	4 540 000	2023-12-31
0,22 %	Artemis Investment Management LLP	3 982 000	0	2023-12-31
0,21 %	MFS Investment Management	3 820 000	0	2023-12-31
0,16 %	Charles Schwab Investment Management, Inc.	2 909 747	106 000	2024-03-31
0,16 %	BlackRock Advisors (UK) Limited	2 825 649	58 000	2024-03-31
0,14 %	California State Teachers Retirement System	2 513 106	74 000	2023-06-30
0,13 %	Jupiter Asset Management Ltd.	2 424 000	510 000	2023-12-31
0,13 %	Value Partners Ltd.	2 350 000	0	2023-12-31
0,12 %	Nordea Funds Oy	2 120 000	0	2024-02-29
0,12 %	1832 Asset Management L.P.	2 098 000	0	2023-12-31
0,11 %	RAM Active Investments S.A.	2 043 862	−177 563	2023-12-31
0,11 %	AllianceBernstein L.P.	1 976 000	0	2024-02-29
0,11 %	Fullgoal Fund Management Co., Ltd.	1 928 000	34 000	2023-12-31
0,11 %	State Street Global Advisors (US)	1 916 500	−50 000	2024-03-31
0,10 %	E Fund Management Co. Ltd.	1 857 209	1 818 424	2023-12-31
0,09 %	Dimensional Fund Advisors, Ltd.	1 687 500	34 000	2024-01-31
0,09 %	JPMorgan Asset Management U.K. Limited	1 624 000	680 000	2024-02-29
0,09 %	SEI Investments Management Corporation	1 561 955	−656 995	2024-03-31
0,08 %	AXA Investment Managers UK Ltd.	1 452 000	0	2024-02-29
0,07 %	East Capital Asset Management AB	1 282 000	1 282 000	2024-02-29
0,06 %	Penghua Fund Management Co., Ltd.	1 160 000	1 160 000	2023-12-31
0,06 %	LähiTapiola Varainhoito Oy	1 068 000	62 000	2024-01-31
0,06 %	Goldman Sachs Asset Management International	1 050 000	0	2023-12-31
0,05 %	Thrivent Asset Management, LLC	894 000	0	2024-01-31
0,05 %	China Asset Management (Hong Kong) Limited	876 784	−52 000	2024-03-31
0,04 %	Lazard Asset Management, L.L.C.	816 000	0	2024-01-31
0,04 %	China Merchants Fund Management Co. Ltd.	792 000	308 000	2023-12-31
0,04 %	LSV Asset Management	772 000	0	2023-12-31
0,04 %	Nuveen LLC	745 562	0	2024-03-31
0,04 %	American Century Investment Management, Inc.	740 000	6 000	2024-03-31
0,04 %	Geode Capital Management, L.L.C.	686 000	0	2024-02-29
0,04 %	HuaAn Fund Management Co., Ltd.	662 000	636 000	2023-12-31
0,03 %	Parametric Portfolio Associates LLC	600 000	0	2023-12-31
0,03 %	UBS Asset Management (UK) Ltd.	566 000	40 000	2024-03-31
0,03 %	China Southern Asset Management Co. Ltd.	548 000	548 000	2023-12-31
0,03 %	Credit Suisse Funds AG	502 000	0	2024-02-29
0,03 %	Margetts Fund Management Limited	498 000	498 000	2023-12-31
0,02 %	Yinhua Fund Management Co., Ltd.	428 000	428 000	2023-12-31
0,02 %	Eika Kapitalforvaltning AS	377 402	0	2024-01-31
0,02 %	ICBC Credit Suisse Asset Management Co. Ltd.	376 000	376 000	2023-06-30
0,02 %	Asset Management One Co., Ltd.	360 000	−322 000	2023-11-30
0,02 %	State Street Global Advisors (Japan) Co., Ltd.	336 000	0	2024-02-29
0,02 %	Segall Bryant & Hamill, LLC	314 000	−60 223	2024-02-29
0,02 %	KLP Fondsforvaltning AS	290 000	130 000	2024-02-29
0,02 %	Zürcher Kantonalbank (Asset Management)	280 000	0	2024-01-31
0,02 %	Russell Investments Limited	278 520	−984	2024-02-29
0,02 %	Northern Trust Global Investments Limited	278 000	0	2023-12-31
0,01 %	JPMorgan Asset Management (China) Company Limited.	268 000	192 000	2023-12-31
0,01 %	BlackRock Investment Management (UK) Ltd.	260 000	0	2023-12-31
0,01 %	WCM Investment Management	252 000	16 000	2023-12-31
0,01 %	BlackRock Asset Management Canada Limited	243 810	0	2024-03-31
0,01 %	Handelsbanken Kapitalförvaltning AB	236 000	−46 000	2024-02-29
0,01 %	Acadian Asset Management LLC	222 000	0	2024-02-29
0,01 %	Fidelity International	208 636	16 231	2024-02-29
0,01 %	Vanguard Investments Australia Ltd.	207 452	−43	2024-02-29
0,01 %	Invesco Capital Management LLC	204 830	−6 590	2024-02-29
0,01 %	Credit Suisse Asset Management (Schweiz) AG	202 000	0	2024-03-31
0,01 %	Zou (Xian Hong)	200 000	0	2023-11-29
0,01 %	Mercer Global Investments Management Ltd	194 000	0	2024-03-31
0,01 %	Simplicity AB	180 000	0	2024-03-31
0,01 %	Allianz Global Investors Asia Pacific Limited	152 000	0	2024-02-29
0,01 %	State Street Global Advisors Ireland Limited	124 000	0	2024-03-31
0,01 %	DFA Australia Ltd.	123 200	207	2023-12-31
0,01 %	Choy (Siu Chit)	117 875	0	2023-11-30
0,01 %	Huatai-PineBridge Fund Management Co., Ltd.	112 000	−28 000	2023-06-30
0,01 %	Legal & General Investment Management Ltd.	96 000	0	2024-02-29
0,01 %	AXA Investment Managers Paris	96 000	20 000	2023-10-31
0,00 %	DWS Investment GmbH	88 115	0	2023-12-31
0,00 %	Lingohr & Partner Asset Management GmbH	84 000	0	2024-01-31
0,00 %	Guliver Anlageberatung GmbH	78 000	0	2024-01-31
0,00 %	Samsung Asset Management Co., Ltd.	72 000	72 000	2023-09-30
0,00 %	Allspring Global Investments, LLC	66 000	0	2024-02-29
0,00 %	Union Investment Privatfonds GmbH	54 000	0	2023-09-30
0,00 %	Vanguard Global Advisers LLC	52 000	0	2024-03-31
0,00 %	Artico Partners AG	50 000	−10 000	2024-03-31
0,00 %	AcomeA SGR S.p.A.	50 000	0	2023-12-31
0,00 %	INVESCO Great Wall Fund Management Co. Ltd.	42 000	12 000	2023-12-31
0,00 %	Finlabo SIM S.p. A.	41 000	0	2024-02-29
0,00 %	Cinda Fund Management Co., Ltd.	39 796	−204	2023-12-31
0,00 %	Pictet Asset Management Ltd.	38 000	0	2023-11-30
0,00 %	Russell Investments Japan Co., Ltd.	36 000	−6 476	2023-08-31
0,00 %	JP Morgan Asset Management	34 000	−2 000	2024-02-29
0,00 %	First Trust Advisors L.P.	32 000	0	2024-02-29
0,00 %	HSBC Global Asset Management (UK) Limited	30 978	0	2024-01-31

What values and corporate philosophy does United Laboratories International Holdings represent?

United Laboratories International Holdings Ltd represents a strong commitment to innovation, quality, and customer satisfaction. The company's corporate philosophy revolves around delivering cutting-edge solutions and services to meet the evolving needs of its clients. United Laboratories International Holdings Ltd places great emphasis on integrity, professionalism, and ethical business practices, ensuring the highest standards across all operations. With a focus on research and development, United Laboratories International Holdings Ltd strives to provide top-tier pharmaceutical and healthcare products that improve the well-being of individuals worldwide. This dedication to excellence and customer-centric approach makes United Laboratories International Holdings Ltd a trusted leader in the industry.

In which countries and regions is United Laboratories International Holdings primarily present?

United Laboratories International Holdings Ltd is primarily present in various countries and regions. This global pharmaceutical company has a strong presence in the United States, China, Europe, Southeast Asia, and South Africa. With a focus on research and development, United Laboratories International Holdings Ltd has established a robust network in these regions, allowing it to deliver high-quality healthcare products and services. By expanding its reach across different markets, the company aims to meet the diverse needs of patients and healthcare professionals worldwide.

What significant milestones has the company United Laboratories International Holdings achieved?

United Laboratories International Holdings Ltd has achieved several significant milestones throughout its history. These milestones include expanding its product portfolio, establishing a strong global presence, and delivering innovative healthcare solutions to millions of people worldwide. The company has successfully launched numerous groundbreaking pharmaceutical and healthcare products, ensuring access to quality healthcare for patients around the globe. Through strategic partnerships and continuous research and development, United Laboratories International Holdings Ltd has consistently demonstrated its commitment to improving the well-being of individuals and communities. These achievements have cemented the company's position as a leader in the healthcare industry.

What is the history and background of the company United Laboratories International Holdings?

United Laboratories International Holdings Ltd, commonly known as United Labs, is a renowned pharmaceutical company with a rich history and extensive background. Founded in [insert year], United Labs has emerged as a global leader in the research, development, and manufacturing of innovative healthcare solutions. With a strong emphasis on cutting-edge technology and a dedicated team of experts, the company has consistently delivered high-quality pharmaceutical products that meet stringent international standards. United Labs has a broad product portfolio encompassing various therapeutic areas, including [mention specific areas]. Over the years, the company has expanded its presence globally, establishing strategic partnerships and subsidiaries, thus cementing its position as an industry leader in the pharmaceutical sector.

Who are the main competitors of United Laboratories International Holdings in the market?

The main competitors of United Laboratories International Holdings Ltd in the market include big players such as Pfizer Inc., Johnson & Johnson, and Novartis AG. These companies are renowned pharmaceutical giants that compete with United Laboratories International Holdings Ltd in terms of product offerings, market share, and global reach.

In which industries is United Laboratories International Holdings primarily active?

United Laboratories International Holdings Ltd is primarily active in the pharmaceutical and healthcare industries.

What is the business model of United Laboratories International Holdings?

The business model of United Laboratories International Holdings Ltd (ULI) revolves around the development, manufacturing, and sale of generic and branded pharmaceutical products. As one of the leading pharmaceutical companies in the Asia Pacific region, ULI aims to provide affordable and high-quality healthcare solutions to patients worldwide. With a focus on research and development, ULI continuously strives to innovate and introduce new products to meet the evolving needs of its customers. By adhering to rigorous quality standards and maintaining strong relationships with healthcare professionals, ULI aims to achieve sustainable growth and contribute to the betterment of global healthcare.

Koks yra United Laboratories International Holdings 2024 KGV?

United Laboratories International Holdings KGV yra 5,34.

Koks United Laboratories International Holdings 2024 KUV?

United Laboratories International Holdings KUV yra 0,99.

Koks yra United Laboratories International Holdings AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis United Laboratories International Holdings yra 8/10.

Koks yra United Laboratories International Holdings 2024 pajamų dydis?

tikėtina United Laboratories International Holdings pardavimai yra 15,09 mlrd. CNY.

Kokia yra United Laboratories International Holdings 2024 pelnas?

tikėtina United Laboratories International Holdings pelnas yra 2,80 mlrd. CNY.

Ką daro United Laboratories International Holdings?

United Laboratories International Holdings Ltd (ULIH) is a globally operating company in the chemical and pharmaceutical industry based in Hong Kong. The company offers a wide range of chemical and pharmaceutical products and manufactures them in various divisions distributed worldwide. ULIH's business model is based on comprehensive research and development work that enables the company to produce innovative products that meet customer needs. The pharmaceutical and chemical industry is one of the most important sectors of the global economy today. It is highly dependent on technological developments and investments in research and development. ULIH's position in the global market is supported by offering a variety of high-quality products divided into different categories such as chemical raw materials, semi-finished products, pharmaceuticals, and health products. ULIH produces and distributes raw materials for pharmaceutical production. Such specialty products are often needed in small quantities, making this product segment an important part of the business. The products include medical gases, API (Active Pharmaceutical Ingredients), and injection fluids, among others. In the production of semi-finished products, the company utilizes various technologies and produces targeted active ingredients, cephalosporins, and steroids, for example. In the field of pharmaceuticals, ULIH offers a wide range of medical products such as antibiotics, anti-tuberculosis drugs, analgesics, anti-rheumatics, and others. Some of the well-known products include chloramphenicol and itraconazole. The company's stated goal is to further expand and optimize its medical products to improve the health and well-being of patients worldwide. Another important business area for ULIH is the offering of health products. The offered products include nutritional supplements, herbal extracts, and other products that can contribute to improving the health and well-being of consumers. The company is also committed to a sustainable business model that focuses on environmental aspects, employees, and the common good. It strives to minimize CO2 emissions and create socially responsible working conditions. The brand is valued in many countries around the world and stands out for its quality and customer satisfaction. In summary, ULIH offers a wide range of products and services tailored to the needs of pharmaceutical and chemical companies, health product manufacturers, and end consumers. The business model is focused on continuous improvement and innovation and seeks long-term customer relationships and partnerships.

Kokia yra United Laboratories International Holdings dividendė?

United Laboratories International Holdings moka dividendą 0,08 CNY, kuris yra paskirstytas per išmokas per metus.

Kiek kartų United Laboratories International Holdings moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota United Laboratories International Holdings arba įmonė dividendų nemoka.

Kas yra United Laboratories International Holdings ISIN?

United Laboratories International Holdings ISIN yra KYG8813K1085.

Kas yra United Laboratories International Holdings WKN?

United Laboratories International Holdings WKN yra A0MUFS.

Kas yra United Laboratories International Holdings Tickeris?

United Laboratories International Holdings akcijų simbolis yra 3933.HK.

Kiek dividendų moka United Laboratories International Holdings?

Per paskutinius 12 mėnesių United Laboratories International Holdings išmokėjo dividendą, kurios dydis siekė 0,20 CNY . Tai atitinka maždaug 2,39 % dividendų grąžą. Artimiausiems 12 mėnesiams United Laboratories International Holdings tikėtina išmokės dividendus, kurie sudarys 0,22 CNY.

Kokia yra United Laboratories International Holdings dividendų grąža?

United Laboratories International Holdings šiuo metu yra 2,39 % dydžio dividendų grąža.

Kada United Laboratories International Holdings moka dividendus?

United Laboratories International Holdings moka dividendus kas ketvirtį. Jie išmokami rugpjūtis, spalis, liepa, rugpjūtis mėnesiais.

Kokia saugi yra United Laboratories International Holdings dividendų išmokėjimas?

United Laboratories International Holdings per paskutiniuosius 9 metus kiekvienais metais mokėjo dividendus.

Kokia yra United Laboratories International Holdings dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0,22 CNY. Tai atitinka 2,69 % dividendų grąžos procentą.

Kokiame sektoriuje yra United Laboratories International Holdings?

United Laboratories International Holdings priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von United Laboratories International Holdings kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį United Laboratories International Holdings dividendą nuo 2024-07-24, kurio dydis yra 0,132 CNY, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-07-02.

Kada United Laboratories International Holdings paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-07-24.

Kokia buvo United Laboratories International Holdings dividendų suma 2023 metais?

2023 metais United Laboratories International Holdings išmokėjo 0,08 CNY dividendų.

Kokia valiuta United Laboratories International Holdings moka dividendus?

United Laboratories International Holdings dividendai yra mokami CNY.

Birža	United Laboratories International Holdings Akcijų kodas
FRANKFURTAS	UNJ.F
HKSE	3933.HK
MIUNCHENAS	UNJ.MU
PNK	ULIHF

United Laboratories International Holdings Akcijų kodas	United Laboratories International Holdings FIGI
3933:HK	BBG000JZ6DW1
UNJ:GR	BBG000RHK0F3
UNJ:GF	BBG000RHK0Y2
UNJ:GS	BBG000RHK1S7
UNJ:GM	BBG000RHK232
UNJ:GB	BBG000RHK2K3
ULIHF:US	BBG001KBT5W2
ULIHF:PQ	BBG001KBT696
ULIHF:UV	BBG001KBT6C2
3933:H2	BBG00F136127
3933HKD:X2	BBG00JQDPJN7
3933HKD:XB	BBG00JQDPJP5
3933HKD:XH	BBG00JQDPJR3
3933HKD:XF	BBG00JQDPJT1
3933HKD:XE	BBG00JQDPJW7
3933HKD:XJ	BBG00JQDPJX6
3933HKD:XL	BBG00JQDPJY5
3933HKD:XG	BBG00JQDPJZ4
3933HKD:XO	BBG00JQDPK09
3933HKD:XS	BBG00JQDPK45
3933HKD:XA	BBG00JQDPK54
3933HKD:E1	BBG00JQDPK63
3933HKD:XT	BBG00JQDPK72
3933HKD:XW	BBG00JQDPK81
3933HKD:XU	BBG00JQDPK90
3933HKD:XV	BBG00JQDPKB7
3933HKD:XM	BBG00JQDPKC6
3933HKD:XQ	BBG00JQDPKF3
3933HKD:XX	BBG00JQDPKG2
3933HKD:XZ	BBG00JQDPKH1
3933HKD:EU	BBG00JQDPKK7
3933HKD:EP	BBG00TDD00N7
3933HKD:EZ	BBG00TDD00Q4
UNJ:GZ	BBG011XLTQ22
3933EUR:XH	BBG011XLW2R4
3933EUR:XF	BBG011XLW2T2
3933EUR:XE	BBG011XLW2W8
3933EUR:XL	BBG011XLW2Y6
3933EUR:XG	BBG011XLW2Z5
3933EUR:XO	BBG011XLW301
3933EUR:XA	BBG011XLW347
3933EUR:XT	BBG011XLW365
3933EUR:XW	BBG011XLW374
3933EUR:XU	BBG011XLW383
3933EUR:XV	BBG011XLW3B9
3933EUR:XM	BBG011XLW3C8
3933EUR:EU	BBG011XLW3L8
UNJ:LA	BBG018H8PSP9
UNJ:LU	BBG018J2BTS0
3933:H1	BBG01FRSSB09

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
1,28	1,81	2,13	2,53	3,35	4,09	5,67	5,32	5,71	6,06	7,19	6,74	6,08	6,83	7,51	8,39	8,77	9,70	11,33	13,74	15,09	15,76	16,37
-	42,04	17,84	18,51	32,54	22,05	38,47	−6,14	7,39	6,15	18,61	−6,23	−9,85	12,33	10,02	11,74	4,53	10,61	16,81	21,22	9,83	4,43	3,90
33,18	34,84	35,38	46,46	38,04	39,06	39,49	28,55	30,16	34,48	40,20	38,48	35,58	36,60	40,64	43,15	43,39	43,40	43,83	46,10	-	-	-
0,42	0,63	0,76	1,18	1,28	1,60	2,24	1,52	1,72	2,09	2,89	2,59	2,16	2,50	3,05	3,62	3,81	4,21	4,97	6,33	0	0	0
0,21	0,24	0,31	0,61	0,56	0,71	1,08	0,28	0,32	0,41	1,29	0,74	0,41	0,69	1,01	1,08	1,25	1,16	2,11	3,28	3,32	3,23	3,32
16,63	13,42	14,29	24,24	16,68	17,26	18,98	5,19	5,52	6,75	17,96	10,99	6,71	10,09	13,38	12,87	14,25	11,94	18,58	23,88	21,98	20,50	20,28
0,14	0,12	0,18	0,50	0,38	0,48	0,85	0,09	0,13	0,04	0,61	0,10	−0,27	0,08	0,68	0,64	0,70	0,99	1,58	2,70	2,80	2,73	2,82
-	−12,86	45,90	179,21	−22,94	24,54	77,78	−89,86	52,33	−70,99	1 502,63	−84,24	−383,33	−129,78	741,98	−6,01	9,52	40,74	60,02	70,84	3,48	−2,25	3,07
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0,98	0,98	0,98	1,16	1,31	1,31	1,36	1,44	1,51	1,63	1,63	1,63	1,63	1,63	1,83	1,64	1,77	1,84	1,82	1,82	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodas3933.HK

ISINKYG8813K1085

VVPA0MUFS

United Laboratories International Holdings akcijų apyvarta, EBIT, pelnas KYG8813K1085 · A0MUFS

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

United Laboratories International Holdings Pajamų, pelno ir EBIT istorija.

United Laboratories International Holdings Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

United Laboratories International Holdings Akcijos Maržos KYG8813K1085 · A0MUFS

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

United Laboratories International Holdings Maržų istorija

United Laboratories International Holdings akcijos apyvarta, EBIT, pelnas vienai akcijai KYG8813K1085 · A0MUFS

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

United Laboratories International Holdings Pardavimų, pelno ir EBIT istorija vienai akcijai

United Laboratories International Holdings akcija ir akcijų analizė

United Laboratories International Holdings įvertinimas pagal istorinį P/E, EBIT ir P/S

United Laboratories International Holdings akcijų skaičius KYG8813K1085 · A0MUFS

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

United Laboratories International Holdings akcijos dividendas KYG8813K1085 · A0MUFS

Dividendas

Dividendų apžvalga

Interpretacija ir naudojimas

Investavimo strategija

United Laboratories International Holdings Dividendų istorija

United Laboratories International Holdings akcijų išmokėjimo koeficientas KYG8813K1085 · A0MUFS

Dividendų mokėjimo rodiklis

Kas yra metinis dividendų mokėjimo rodiklis?

Kaip interpretuoti duomenis

Duomenų naudojimas investavimui

United Laboratories International Holdings Dividendų išmokėjimo istorija

United Laboratories International Holdings Pelno prognozės

United Laboratories International Holdings Pelnų staigmenos

United Laboratories International Holdings akcijos akcininkų struktūra

United Laboratories International Holdings Valdyba ir Priežiūros taryba

Dažnai užduodami klausimai apie United Laboratories International Holdings akciją